Startseite Medizin Oxidative Stress in Diabetes
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Oxidative Stress in Diabetes

  • Ludovica Piconi , Lisa Quagliaro und Antonio Ceriello
Veröffentlicht/Copyright: 1. Juni 2005
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 41 Heft 9

Abstract

Increasing evidence in both experimental and clinical studies suggests that there is a close link between hyperglycemia, oxidative stress and diabetic complications. High blood glucose level determines overproduction of reactive oxygen species (ROS) by the mitochondria electron transport chain. High reactivity of ROS determines chemical changes in virtually all cellular components, leading to DNA and protein modification and lipid peroxidation. Measurement of biomarkers such 8-hydroxy-2′deoxyguanosine (8-OHdG), isoprostanes, malondialdehyde (MDA) and nitrotyrosine is a useful tool to assess the oxidative stress of the organism. Knowledge of the mechanisms of ROS damage of is the first step for development of new therapeutic molecules and for rationalizing the use of existing drugs.

:
Published Online: 2005-06-01
Published in Print: 2003-09-16

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Editors' Introduction: Welcome to the Special Issue on Diabetes Mellitus
  2. Linking Research and Innovative Clinical Practice: The Story of Diabetes Mellitus
  3. Insulin Resistant States and Insulin Signaling
  4. Diabesity: An Inflammatory Metabolic Condition
  5. Plasma Adiponectin and Hyperglycaemia in Diabetic Patients
  6. Platelet Function and Acetyl-Coenzyme A Metabolism in Type 1 Diabetes Mellitus
  7. Oxidative Stress in Diabetes
  8. Carbonyl Stress and Diabetic Complications
  9. Chemical Modification of Proteins by Lipids in Diabetes
  10. Glyoxal and Methylglyoxal Levels in Diabetic Patients: Quantitative Determination by a New GC/MS Method
  11. Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease
  12. Haemoglobin A1c – A Marker for Complications of Type 2 Diabetes: The Experience from the UK Prospective Diabetes Study (UKPDS)
  13. Glycated Hemoglobin Standardization – National Glycohemoglobin Standardization Program (NGSP) Perspective
  14. Haemoglobin A1c: Analysis and Standardisation
  15. Point-of-Care Testing in Diabetes Mellitus
  16. Evaluation of Portable Blood Glucose Meters. Problems and Recommendations
  17. Measurements of Glucose on the Skin Surface, in Stratum Corneum and in Transcutaneous Extracts: Implications for Physiological Sampling
  18. Biological Variability of Albumin Excretion Rate and Albumin-to-Creatinine Ratio in Hypertensive Type 2 Diabetic Patients
  19. Clinical and Laboratory Evaluation of Specific Chemiluminescence Assays for Intact and Total Proinsulin
  20. Clinical Impact of the New Criteria for the Diagnosis of Diabetes Mellitus
  21. The Effect of the New ADA and WHO Guidelines on the Number of Diagnosed Cases of Diabetes Mellitus
  22. Detecting Type 2 Diabetes by a Single Post-Challenge Blood Sample
  23. Laboratory Tests in Diagnosis and Management of Diabetes Mellitus. Practical Considerations
  24. Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine
  25. Meetings and Awards
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.177/html
Button zum nach oben scrollen